MIRA Pharmaceuticals (MIRA) vs Nasus Pharma (NSRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MIRA Pharmaceuticals (MIRA) has outperformed Nasus Pharma (NSRX) over the past year, losing 44.4% versus a loss of 54.7%. Nasus Pharma is the larger company by market cap ($41.1 million vs $31.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIRA | NSRX |
|---|---|---|
| Share price | $0.7455 | $3.51 |
| Market cap | $31.33M | $41.12M |
| 1-day change | +6.05% | -3.31% |
| YTD return | -50.63% | -61.64% |
| 1-year return | -44.37% | -54.71% |
| EPS (TTM) | $-1.14 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.45 | $9.50 |
| 52-week low | $0.60 | $1.98 |
| Distance from 52-week high | -69.57% | -63.05% |
| Analyst consensus | none | buy |
| Avg. price target upside | +369.48% | +460.40% |
| Average volume | 585.75K | 16.02K |
| Shares outstanding | 42.02M | 11.71M |
| Employees | — | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MIRA has outperformed NSRX by 10.3 percentage points over the past year.
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
About Nasus Pharma
NSRX stock →Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
MIRA vs NSRX FAQ
Which is bigger, MIRA Pharmaceuticals or Nasus Pharma?
Nasus Pharma (NSRX) is larger, with a market capitalization of $41.12M compared with $31.33M for MIRA Pharmaceuticals (MIRA).
Which stock has performed better over the past year, MIRA or NSRX?
MIRA returned -44.37% over the past 12 months, compared with -54.71% for NSRX (price return, excluding dividends). Past performance does not predict future results.
Are MIRA Pharmaceuticals and Nasus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.